Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,599.50
Bid: 1,604.00
Ask: 1,604.50
Change: 4.50 (0.28%)
Spread: 0.50 (0.031%)
Open: 1,600.50
High: 1,612.50
Low: 1,591.00
Prev. Close: 1,595.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks flat on euro uncertainty

Tue, 12th Jun 2012 08:40

- Markets still digesting Spanish request for aid- Investors look ahead to Greek elections, Italian bond auction- Miners and banks drop early onLondon's blue-chip index opened flat on Tuesday morning with all eyes on the Eurozone following the recent Spanish request for aid and ahead of the crucial Greek elections at the weekend.Stocks opened strongly yesterday after Spain requested a credit line of up to €100bn to help recapitalise its banks, but gains were quickly pared as the markets digested what this would mean in the longer term."There is still the Greece election this coming weekend and beyond this no shortage of concerns and areas of vulnerability throughout the Eurozone. This crisis will rumble on," said RBS's chief economist Andrew McLaughlin yesterday.Italy also remains a worry for investors as the country's benchmark bond yields tracked Spanish rates higher yesterday ahead of a bond auction later this week.International Monetary Fund (IMF) Managing Director Christine Lagarde has denied that there is a three-month make-or-break deadline for the euro despite billionaire investor George Soros's prediction last week that the Eurozone had only that much time to fix its problems.Meanwhile, European Commission (EC) President José Manuel Barroso has called on EU leaders to take a "big step" and agree on a banking union to be implemented as early as next year. FTSE 100: Miners, banks hit by risk aversionMining stocks were out of favour as investors shied away from risk on the back of the Eurozone uncertainty: Evraz, Kazakhmys, ENRC and Antofagasta were registering moderate falls in the opening hour, as too were potential merger partners Glencore and Xstrata. In a research note this morning, Jefferies said that certain factors have reduced the pressure on Glencore to bump up its offer for Xstrata shareholders and said that the ratio of 2.8 Glencore shares per Xstrata share is now expected to succeed.Banks were also under some selling pressure early on with Barclays RBS and Lloyds among the worst performers. Lloyds is taking the first step to getting out of Japan after announcing the sale of its remittance business in the country. The group, which is 43% owned by the UK taxpayer, is selling GoLloyds to Shinsei Bank.Supermarket firm Sainsbury was on the up after making a surprise move into the e-book retail market with the acquisition of HMV's stake in online venture Anobii. Pharmaceuticals giant GlaxoSmithKline edged higher after signing an agreement to buy eczema treatment drug 'Toctino' from Basilea Pharmaceutica for an initial payment of £146m in cash.FTSE 250: RPC, Spirit drop after resultsPlastic packaging firm RPC Group slumped despite hiking its dividend after the successful acquisition of food packaging firm Superfos helped drive up profits in the year to the end of March.Like-for-like sales growth slowed at Spirit as the pubs group ran into stronger comparatives from a year earlier, while things are getting worse in the group's leased estate, causing shares to fall early on.Insurance group Amlin was a high riser after Deutsche Bank upgraded its rating on the stock to buy and lifted its target price from 420p to 435p. Meanwhile, airline easyJet was under the weather after a HSBC downgrade to neutral.FTSE 100 - RisersICAP (IAP) 344.60p +2.16%British American Tobacco (BATS) 3,163.00p +1.67%Admiral Group (ADM) 1,091.00p +1.49%Unilever (ULVR) 2,063.00p +1.23%Schroders (Non-Voting) (SDRC) 995.00p +1.22%Serco Group (SRP) 551.00p +0.92%Vodafone Group (VOD) 172.60p +0.91%Schroders (SDR) 1,257.00p +0.88%Imperial Tobacco Group (IMT) 2,399.00p +0.88%Severn Trent (SVT) 1,804.00p +0.84%FTSE 100 - FallersEvraz (EVR) 264.90p -2.82%Barclays (BARC) 185.80p -2.49%ARM Holdings (ARM) 494.40p -2.20%Royal Bank of Scotland Group (RBS) 216.70p -2.12%Petrofac Ltd. (PFC) 1,505.00p -1.76%ITV (ITV) 71.15p -1.52%Kazakhmys (KAZ) 682.50p -1.44%Eurasian Natural Resources Corp. (ENRC) 401.00p -1.43%Man Group (EMG) 75.65p -1.37%Weir Group (WEIR) 1,430.00p -1.31%FTSE 250 - RisersNorthgate (NTG) 173.10p +4.91%Centamin (DI) (CEY) 70.05p +4.40%Amlin (AML) 335.60p +3.74%Ruspetro (RPO) 153.00p +3.73%Rank Group (RNK) 121.10p +3.50%IG Group Holdings (IGG) 456.20p +1.92%New World Resources A Shares (NWR) 312.10p +1.89%Big Yellow Group (BYG) 282.60p +1.51%Petra Diamonds Ltd.(DI) (PDL) 128.80p +1.34%Cape (CIU) 266.10p +1.29%FTSE 250 - FallersRPC Group (RPC) 370.10p -6.78%Bumi (BUMI) 351.00p -3.84%Spirit Pub Company (SPRT) 46.00p -3.66%easyJet (EZJ) 486.20p -2.74%Talvivaara Mining Company (TALV) 143.40p -2.45%Redrow (RDW) 111.00p -2.37%Fenner (FENR) 357.30p -2.32%Aquarius Platinum Ltd. (AQP) 64.00p -2.29%Regus (RGU) 87.70p -2.23%Savills (SVS) 319.60p -2.17%BC
More News
26 Jun 2024 22:50

US CDC narrows age recommendation for RSV shots in US

June 26 (Reuters) - The U.S. CDC on Wednesday narrowed its recommendation for use of respiratory syncytial virus vaccines in older adults this year and held off on recommending their use for adults under age 60.

Read more
26 Jun 2024 11:00

US advisers to consider RSV shots as GSK looks to keep market lead

June 26 (Reuters) - A committee of outside experts to the U.S. CDC are set to vote on whether to expand the age group of adults who should receive respiratory syncytial virus (RSV) vaccines this year, as GSK battles rival Pfizer and new entrant Moderna to keep its top position in the market.

Read more
25 Jun 2024 08:25

Merck KGaA shares plunge after cancer drug hopeful fails

FRANKFURT, June 25 (Reuters) - Shares in Germany's Merck KGaA slumped 8.9% at the open on Tuesday after the diversified group late on Monday said a trial testing a head and neck cancer drug, previously seen as promising, would be stopped for lack of efficacy.

Read more
24 Jun 2024 08:55

TOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EU

(Alliance News) - GSK PLC on Monday said it has landed an approval in Japan and also highlighted regulatory progress in the EU.

Read more
24 Jun 2024 07:43

LONDON BRIEFING: Prudential announces buyback; Frasers and THG in deal

(Alliance News) - London's FTSE 100 is called to open lower at the start of the week, with share price falls for major US tech shares, Nvidia included, spooking investors on this side of the Atlantic.

Read more
24 Jun 2024 07:21

GSK reports regulatory progress for Omjjara, Jemperli

(Sharecast News) - GSK announced on Monday that it has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for 'Omjjara', or momelotinib, as a treatment for myelofibrosis.

Read more
20 Jun 2024 16:01

Industry groups back drugmakers' appeal in Zantac cancer lawsuits

June 20 (Reuters) - A bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued heartburn drug Zantac has received the backing of leading U.S. industry groups, including the United States Chamber of Commerce and Pharmaceutical Research and Manufacturers of America.

Read more
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.